Home > > > > > Report Detail

Global Paclitaxel Market Research Report 2022 (Status and Outlook)

Publisher Name :
Date: 02-Feb-2022
No. of pages: 114

Report Overview:

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy.

The global Paclitaxel Market Size was estimated at USD 115.88 million in 2021 and is projected to reach USD 201.19 million by 2028, exhibiting a CAGR of 8.20% during the forecast period.

Bosson Research's latest report provides a deep insight into the global Paclitaxel market covering all its essential aspects. This ranges from macro-overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies to the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of Global Paclitaxel Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Paclitaxel market in any manner.

Global Paclitaxel Market: Market Segmentation Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Market segmentation creates subsets of a market based on product type, end user or application, Geographic, and other factor. By understanding the market segments, decision maker can leverage this targeting in product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Phyton

ScinoPharm

Novasep

Samyang

Polymed

TAPI (Teva)

Fresenius-kabi

Huiang biopharma

Southpharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

Market Segmentation (by Type)

Natural Paclitaxel API

Semi-synthetic Paclitaxel API

Market Segmentation (by Application)

Ovarian Cancer

Cervical Cancer

Breast Cancer

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

- Industry drivers, restraints, and opportunities covered in the study

- Neutral perspective on the market performance

- Recent industry trends and developments

- Competitive landscape & strategies of key players

- Potential & niche segments and regions exhibiting promising growth covered

- Historical, current, and projected market size, in terms of value

- In-depth analysis of the Biobased Transformer Oil Market

- Overview of the regional outlook of the Biobased Transformer Oil Market:

Key Reasons to Buy this Report:

- Access to up to date statistics compiled by our own researchers. These provide you with historical and forecast data, which is analysed to tell you why your market is set to change

- This enables you to anticipate market changes in order to remain ahead of your competitors

- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentation or other strategic documents

- The concise analysis, clear graph and table format will enable you to pin point the information your require quickly

- Provision of market value (USD Billion) data for each segment and sub-segment

- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

- Includes in-depth analysis of the market of various perspectives through Porter's five forces analysis

- Provides insight into the market through Value Chain

- Market dynamics scenario, along with growth opportunities of the market in the years to come

- 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.

Global Paclitaxel Market Research Report 2022 (Status and Outlook)

TABLE OF CONTENTS
1 Research Methodology and Statistical Scope 1
1.1 Market Definition and Statistical Scope of Paclitaxel 1
1.2 Key Market Segments 1
1.2.1 Paclitaxel Segment by Type 1
1.2.2 Paclitaxel Segment by Application 2
1.3 Methodology & Sources of Information 3
1.3.1 Research Methodology 3
1.3.2 Research Process 4
1.3.3 Market Breakdown and Data Triangulation 5
1.3.4 Base Year 5
1.3.5 Report Assumptions & Caveats 6
2 Paclitaxel Market Overview 8
2.1 Global Market Overview 8
2.1.1 Global Paclitaxel Market Size (M USD) Estimates and Forecasts (2017-2028) 8
2.1.2 Global Paclitaxel Sales Estimates and Forecasts (2017-2028) 9
2.2 Market Segment Executive Summary 9
2.3 Global Market Size by Region 11
3 Paclitaxel Market Competitive Landscape 13
3.1 Global Paclitaxel Sales by Manufacturers (2017-2022) 13
3.2 Global Paclitaxel Revenue Market Share by Manufacturers (2017-2022) 15
3.3 Paclitaxel Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16
3.4 Global Paclitaxel Average Price by Manufacturers (2017-2022) 17
3.5 Manufacturers Paclitaxel Sales Sites, Area Served, Product Type 18
3.6 Paclitaxel Market Competitive Situation and Trends 19
3.6.1 Paclitaxel Market Concentration Rate 19
3.6.2 Global 5 and 10 Largest Paclitaxel Players Market Share by Revenue 21
3.6.3 Mergers & Acquisitions, Expansion 21
4 Paclitaxel Industry Chain Analysis 22
4.1 Paclitaxel Industry Chain Analysis 22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 22
4.3 Midstream Market Analysis 23
4.4 Downstream Customer Analysis 23
5 The Development and Dynamics of Paclitaxel Market 25
5.1 Key Development Trends 25
5.2 Driving Factors 25
5.3 Market Challenges 25
5.4 Market Restraints 26
5.5 Industry News 26
5.5.1 New Product Developments 26
5.5.2 Mergers & Acquisitions 26
5.5.3 Expansions 26
5.5.4 Collaboration/Supply Contracts 26
5.6 Industry Policies 26
6 Paclitaxel Market Segmentation by Type 27
6.1 Evaluation Matrix of Segment Market Development Potential (Type) 27
6.2 Global Paclitaxel Sales Market Share by Type (2017-2022) 28
6.3 Global Paclitaxel Market Size Market Share by Type (2017-2022) 29
6.4 Global Paclitaxel Price by Type (2017-2022) 30
7 Paclitaxel Market Segmentation by Application 31
7.1 Evaluation Matrix of Segment Market Development Potential (Application) 31
7.2 Global Paclitaxel Market Sales by Application (2017-2022) 32
7.3 Global Paclitaxel Market Size (M USD) by Application (2017-2022) 33
7.4 Global Paclitaxel Sales Growth Rate by Application (2017-2022) 34
8 Paclitaxel Market Segmentation by Region 35
8.1 Global Paclitaxel Sales by Region 35
8.1.1 Global Paclitaxel Sales by Region 35
8.1.2 Global Paclitaxel Sales Market Share by Region 35
8.2 North America 36
8.2.1 North America Paclitaxel Sales by Country 36
8.2.2 U.S. 37
8.2.3 Canada 37
8.2.4 Mexico 37
8.3 Europe 37
8.3.1 Europe Paclitaxel Sales by Country 38
8.3.2 Germany 38
8.3.3 France 38
8.3.4 U.K. 38
8.3.5 Italy 39
8.3.6 Russia 39
8.4 Asia Pacific 39
8.4.1 Asia Pacific Paclitaxel Sales by Region 39
8.4.2 China 40
8.4.3 Japan 40
8.4.4 South Korea 40
8.4.5 India 40
8.4.6 Southeast Asia 40
8.5 South America 40
8.5.1 South America Paclitaxel Sales by Country 41
8.5.2 Brazil 41
8.5.3 Argentina 41
8.5.4 Columbia 41
8.6 Middle East and Africa 41
8.6.1 Middle East and Africa Paclitaxel Sales by Region 42
8.6.2 Saudi Arabia 42
8.6.3 UAE 42
8.6.4 Egypt 42
8.6.5 Nigeria 43
8.6.6 South Africa 43
9 Key Companies Profiled 44
9.1 Phyton 44
9.1.1 Phyton Paclitaxel Basic Information 44
9.1.2 Phyton Paclitaxel Product Overview 44
9.1.3 Phyton Paclitaxel Product Market Performance 44
9.1.4 Phyton Business Overview 45
9.1.5 Phyton Paclitaxel SWOT Analysis 45
9.1.6 Phyton Recent Developments 45
9.2 ScinoPharm 46
9.2.1 ScinoPharm Paclitaxel Basic Information 46
9.2.2 ScinoPharm Paclitaxel Product Overview 46
9.2.3 ScinoPharm Paclitaxel Product Market Performance 46
9.2.4 ScinoPharm Business Overview 47
9.2.5 ScinoPharm Paclitaxel SWOT Analysis 47
9.2.6 ScinoPharm Recent Developments 47
9.3 Novasep 47
9.3.1 Novasep Paclitaxel Basic Information 47
9.3.2 Novasep Paclitaxel Product Overview 48
9.3.3 Novasep Paclitaxel Product Market Performance 48
9.3.4 Novasep Business Overview 48
9.3.5 Novasep Paclitaxel SWOT Analysis 49
9.3.6 Novasep Recent Developments 49
9.4 Samyang 49
9.4.1 Samyang Paclitaxel Basic Information 49
9.4.2 Samyang Paclitaxel Product Overview 50
9.4.3 Samyang Paclitaxel Product Market Performance 50
9.4.4 Samyang Business Overview 50
9.4.5 Samyang Paclitaxel SWOT Analysis 50
9.4.6 Samyang Recent Developments 51
9.5 Polymed 51
9.5.1 Polymed Paclitaxel Basic Information 51
9.5.2 Polymed Paclitaxel Product Overview 51
9.5.3 Polymed Paclitaxel Product Market Performance 52
9.5.4 Polymed Business Overview 52
9.5.5 Polymed Paclitaxel SWOT Analysis 52
9.5.6 Polymed Recent Developments 52
9.6 TAPI (Teva) 53
9.6.1 TAPI (Teva) Paclitaxel Basic Information 53
9.6.2 TAPI (Teva) Paclitaxel Product Overview 53
9.6.3 TAPI (Teva) Paclitaxel Product Market Performance 53
9.6.4 TAPI (Teva) Business Overview 54
9.6.5 TAPI (Teva) Recent Developments 54
9.7 Fresenius-kabi 54
9.7.1 Fresenius-kabi Paclitaxel Basic Information 54
9.7.2 Fresenius-kabi Paclitaxel Product Overview 55
9.7.3 Fresenius-kabi Paclitaxel Product Market Performance 55
9.7.4 Fresenius-kabi Business Overview 55
9.7.5 Fresenius-kabi Recent Developments 55
9.8 Huiang biopharma 56
9.8.1 Huiang biopharma Paclitaxel Basic Information 56
9.8.2 Huiang biopharma Paclitaxel Product Overview 56
9.8.3 Huiang biopharma Paclitaxel Product Market Performance 56
9.8.4 Huiang biopharma Business Overview 57
9.8.5 Huiang biopharma Recent Developments 57
9.9 Southpharma 57
9.9.1 Southpharma Paclitaxel Basic Information 57
9.9.2 Southpharma Paclitaxel Product Overview 58
9.9.3 Southpharma Paclitaxel Product Market Performance 58
9.9.4 Southpharma Business Overview 58
9.9.5 Southpharma Recent Developments 58
9.10 Yunnan Hande 59
9.10.1 Yunnan Hande Paclitaxel Basic Information 59
9.10.2 Yunnan Hande Paclitaxel Product Overview 59
9.10.3 Yunnan Hande Paclitaxel Product Market Performance 59
9.10.4 Yunnan Hande Business Overview 60
9.10.5 Yunnan Hande Recent Developments 60
9.11 Hainan Yew Pharm 60
9.11.1 Hainan Yew Pharm Paclitaxel Basic Information 60
9.11.2 Hainan Yew Pharm Paclitaxel Product Overview 61
9.11.3 Hainan Yew Pharm Paclitaxel Product Market Performance 61
9.11.4 Hainan Yew Pharm Business Overview 61
9.11.5 Hainan Yew Pharm Recent Developments 61
9.12 Jiangsu Yew Biotechnology 62
9.12.1 Jiangsu Yew Biotechnology Paclitaxel Basic Information 62
9.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Overview 62
9.12.3 Jiangsu Yew Biotechnology Paclitaxel Product Market Performance 62
9.12.4 Jiangsu Yew Biotechnology Business Overview 63
9.12.5 Jiangsu Yew Biotechnology Recent Developments 63
10 Paclitaxel Market Forecast by Region 106
10.1 Global Paclitaxel Market Size Forecast 106
10.2 Global Paclitaxel Market Forecast by Region 106
10.2.1 North America Market Size Forecast by Country 107
10.2.2 Europe Paclitaxel Market Size Forecast by Country 108
10.2.3 Asia Pacific Paclitaxel Market Size Forecast by Region 108
10.2.4 South America Paclitaxel Market Size Forecast by Country 109
10.2.5 Middle East and Africa Forecasted Consumption of Paclitaxel by Country 109
11 Forecast Market by Type and by Application (2022-2028) 111
11.1 Global Paclitaxel Market Forecast by Type (2022-2028) 111
11.1.1 Global Forecasted Sales of Paclitaxel by Type (2022-2028) 111
11.1.2 Global Paclitaxel Market Size Forecast by Type (2022-2028) 111
11.1.3 Global Forecasted Price of Paclitaxel by Type (2022-2028) 112
11.2 Global Paclitaxel Market Forecast by Application (2022-2028) 112
11.2.1 Global Paclitaxel Sales (K Units) Forecast by Application 112
11.2.2 Global Paclitaxel Market Size (M USD) Forecast by Application (2022-2028) 113
12 Conclusion and Key Findings 114


List of Tables

Table 1. Global Paclitaxel Sales (K Units) by Manufacturers (2017-2022) 1
Table 2. Global Paclitaxel Sales Market Share by Manufacturers (2017-2022) 2
Table 3. Global Paclitaxel Revenue (M USD) by Manufacturers (2017-2022) 3
Table 4. Global Paclitaxel Revenue Share by Manufacturers (2017-2022) 3
Table 5. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel as of 2020) 4
Table 6. Global Market Paclitaxel Average Price (USD/Unit) of Key Manufacturers (2017-2022) 5
Table 7. Manufacturers Paclitaxel Sales Sites and Area Served 6
Table 8. Manufacturers Paclitaxel Product Type 6
Table 9. Global Paclitaxel Manufacturers Market Concentration Ratio (CR5 and HHI) 8
Table 10. Mergers & Acquisitions, Expansion Plans 9
Table 11. Industry Chain Map of Paclitaxel 10
Table 12. Raw Materials 10
Table 13. Midstream Market Analysis 11
Table 14. Downstream Customer Analysis 11
Table 15. Key Development Trends 13
Table 16. Driving Factors 13
Table 17. Paclitaxel Market Challenges 13
Table 18. Market Restraints 14
Table 19. Global Paclitaxel Sales by Type (K Units) 15
Table 20. Global Paclitaxel Market Size by Type (M USD) 16
Table 21. Global Paclitaxel Sales (K Units) by Type (2017-2022) 16
Table 22. Global Paclitaxel Sales Market Share by Type (2017-2022) 16
Table 23. Global Paclitaxel Market Size (M USD) by Type (2017-2022) 17
Table 24. Global Paclitaxel Market Size Share by Type (2017-2022) 17
Table 25. Global Paclitaxel Price (USD/Unit) by Type (2017-2022) 18
Table 26. Global Paclitaxel Sales (K Units) by Application 19
Table 27. Global Paclitaxel Market Size by Application 20
Table 28. Global Paclitaxel Sales by Application (2017-2022) & (K Units) 20
Table 29. Global Paclitaxel Sales Market Share by Application (2017-2022) 20
Table 30. Global Paclitaxel Sales by Application (2017-2022) & (M USD) 21
Table 31. Global Paclitaxel Market Share by Application (2017-2022) 21
Table 32. Global Paclitaxel Sales Growth Rate by Application (2017-2022) 22
Table 33. Global Paclitaxel Sales by Region (2017-2022) & (K Units) 23
Table 34. Global Paclitaxel Sales Market Share by Region (2017-2022) 23
Table 35. North America Paclitaxel Sales by Country (2017-2022) & (K Units) 24
Table 36. Europe Paclitaxel Sales by Country (2017-2022) & (K Units) 26
Table 37. Asia Pacific Paclitaxel Sales by Region (2017-2022) & (K Units) 27
Table 38. South America Paclitaxel Sales by Country (2017-2022) & (K Units) 29
Table 39. Middle East and Africa Paclitaxel Sales by Region (2017-2022) & (K Units) 30
Table 40. Phyton Paclitaxel Basic Information 32
Table 41. Phyton Paclitaxel Product Overview 32
Table 42. Phyton Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 32
Table 43. Phyton Business Overview 33
Table 44. Phyton Paclitaxel SWOT Analysis 33
Table 45. Phyton Recent Developments 33
Table 46. ScinoPharm Paclitaxel Basic Information 34
Table 47. ScinoPharm Paclitaxel Product Overview 34
Table 48. ScinoPharm Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 34
Table 49. ScinoPharm Business Overview 35
Table 50. ScinoPharm Paclitaxel SWOT Analysis 35
Table 51. ScinoPharm Recent Developments 35
Table 52. Novasep Paclitaxel Basic Information 35
Table 53. Novasep Paclitaxel Product Overview 36
Table 54. Novasep Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 36
Table 55. Novasep Business Overview 36
Table 56. Novasep Paclitaxel SWOT Analysis 37
Table 57. Novasep Recent Developments 37
Table 58. Samyang Paclitaxel Basic Information 37
Table 59. Samyang Paclitaxel Product Overview 38
Table 60. Samyang Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 38
Table 61. Samyang Business Overview 38
Table 62. Samyang Paclitaxel SWOT Analysis 38
Table 63. Samyang Recent Developments 39
Table 64. Polymed Paclitaxel Basic Information 39
Table 65. Polymed Paclitaxel Product Overview 39
Table 66. Polymed Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 40
Table 67. Polymed Business Overview 40
Table 68. Polymed Paclitaxel SWOT Analysis 40
Table 69. Polymed Recent Developments 40
Table 70. TAPI (Teva) Paclitaxel Basic Information 41
Table 71. TAPI (Teva) Paclitaxel Product Overview 41
Table 72. TAPI (Teva) Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 41
Table 73. TAPI (Teva) Business Overview 42
Table 74. TAPI (Teva) Recent Developments 42
Table 75. Fresenius-kabi Paclitaxel Basic Information 42
Table 76. Fresenius-kabi Paclitaxel Product Overview 43
Table 77. Fresenius-kabi Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 43
Table 78. Fresenius-kabi Business Overview 43
Table 79. Fresenius-kabi Recent Developments 43
Table 80. Huiang biopharma Paclitaxel Basic Information 44
Table 81. Huiang biopharma Paclitaxel Product Overview 44
Table 82. Huiang biopharma Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 44
Table 83. Huiang biopharma Business Overview 45
Table 84. Huiang biopharma Recent Developments 45
Table 85. Southpharma Paclitaxel Basic Information 45
Table 86. Southpharma Paclitaxel Product Overview 46
Table 87. Southpharma Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 46
Table 88. Southpharma Business Overview 46
Table 89. Southpharma Recent Developments 46
Table 90. Yunnan Hande Paclitaxel Basic Information 47
Table 91. Yunnan Hande Paclitaxel Product Overview 47
Table 92. Yunnan Hande Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 47
Table 93. Yunnan Hande Business Overview 48
Table 94. Yunnan Hande Recent Developments 48
Table 95. Hainan Yew Pharm Paclitaxel Basic Information 48
Table 96. Hainan Yew Pharm Paclitaxel Product Overview 49
Table 97. Hainan Yew Pharm Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 49
Table 98. Hainan Yew Pharm Business Overview 49
Table 99. Hainan Yew Pharm Recent Developments 49
Table 100. Jiangsu Yew Biotechnology Paclitaxel Basic Information 50
Table 101. Jiangsu Yew Biotechnology Paclitaxel Product Overview 50
Table 102. Jiangsu Yew Biotechnology Paclitaxel Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 50
Table 103. Jiangsu Yew Biotechnology Business Overview 51
Table 104. Jiangsu Yew Biotechnology Recent Developments 51
Table 105. Global Paclitaxel Sales Forecast by Region (K Units) 94
Table 106. Global Paclitaxel Market Size Forecast by Region (M USD) 95
Table 107. North America Paclitaxel Sales Forecast by Country (2022-2028) & (K Units) 95
Table 108. North America Paclitaxel Market Size Forecast by Country (2022-2028) & (M USD) 95
Table 109. Europe Paclitaxel Sales Forecast by Country (2022-2028) & (K Units) 96
Table 110. Europe Paclitaxel Market Size Forecast by Country (2022-2028) & (M USD) 96
Table 111. Asia Pacific Paclitaxel Sales Forecast by Region (2022-2028) & (K Units) 96
Table 112. Asia Pacific Paclitaxel Market Size Forecast by Region (2022-2028) & (M USD) 97
Table 113. South America Paclitaxel Sales Forecast by Country (2022-2028) & (K Units) 97
Table 114. South America Paclitaxel Market Size Forecast by Country (2022-2028) & (M USD) 97
Table 115. Middle East and Africa Paclitaxel Consumption Forecast by Country (2022-2028) & (Units) 97
Table 116. Middle East and Africa Paclitaxel Market Size Forecast by Country (2022-2028) & (M USD) 98
Table 117. Global Paclitaxel Sales Forecast by Type (2022-2028) & (K Units) 99
Table 118. Global Paclitaxel Market Size Forecast by Type (2022-2028) & (M USD) 99
Table 119. Global Paclitaxel Price Forecast by Type (2022-2028) & (USD/Unit) 100
Table 120. Global Paclitaxel Sales (K Units) Forecast by Application (2022-2028) 100
Table 121. Global Paclitaxel Market Size Forecast by Application (2022-2028) & (M USD) 101

LIST OF FIGURES
Figure 1. Paclitaxel Sales Share by Manufacturers in 2020 2
Figure 2. Global Paclitaxel Revenue Share by Manufacturers in 2020 4
Figure 3. Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 5
Figure 4. Global Market Paclitaxel Average Price (USD/Unit) of Key Manufacturers in 2020 6
Figure 5. The Global 5 and 10 Largest Players: Market Share by Paclitaxel Revenue in 2020 9
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type) 15
Figure 7. Global Paclitaxel Market Share by Type 16
Figure 8. Sales Market Share of Paclitaxel by Type (2017-2022) 17
Figure 9. Sales Market Share of Paclitaxel by Type in 2020 17
Figure 10. Market Size Share of Paclitaxel by Type (2017-2022) 17
Figure 11. Market Size Market Share of Paclitaxel by Type in 2020 18
Figure 12. Global Paclitaxel Market Share by Application 20
Figure 13. Global Paclitaxel Sales Market Share by Application (2017-2022) 21
Figure 14. Global Paclitaxel Sales Market Share by Application in 2020 21
Figure 15. Global Paclitaxel Market Share by Application (2017-2022) 22
Figure 16. Global Paclitaxel Market Share by Application in 2020 22
Figure 17. Global Paclitaxel Sales Growth Rate by Application (2017-2022) 22
Figure 18. Global Paclitaxel Sales Market Share by Region (2017-2022) 23
Figure 19. North America Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 24
Figure 20. North America Paclitaxel Sales Market Share by Country in 2020 24
Figure 21. U.S. Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 25
Figure 22. Canada Paclitaxel Sales (K Units) and Growth Rate (2017-2022) 25
Figure 23. Mexico Paclitaxel Sales (Units) and Growth Rate (2017-2022) 25
Figure 24. Europe Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 25
Figure 25. Europe Paclitaxel Sales Market Share by Country in 2020 26
Figure 26. Germany Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 27. France Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 28. U.K. Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 29. Italy Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 27
Figure 30. Russia Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 27
Figure 31. Asia Pacific Paclitaxel Sales and Growth Rate (K Units) 27
Figure 32. Asia Pacific Paclitaxel Sales Market Share by Region in 2020 27
Figure 33. China Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 34. Japan Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 35. South Korea Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 36. India Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 37. Southeast Asia Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 38. South America Paclitaxel Sales and Growth Rate (K Units) 28
Figure 39. South America Paclitaxel Sales Market Share by Country in 2020 29
Figure 40. Brazil Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 41. Argentina Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 42. Columbia Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 43. Middle East and Africa Paclitaxel Sales and Growth Rate (K Units) 29
Figure 44. Middle East and Africa Paclitaxel Sales Market Share by Region in 2020 30
Figure 45. Saudi Arabia Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 46. UAE Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 47. Egypt Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 48. Nigeria Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 31
Figure 49. South Africa Paclitaxel Sales and Growth Rate (2017-2022) & (K Units) 31
Figure 50. Global Paclitaxel Sales Forecast by Volume (2017-2028) & (K Units) 94
Figure 51. Global Paclitaxel Market Size Forecast by Value (2017-2028) & (M USD) 94
Figure 52. Global Paclitaxel Sales Market Share Forecast by Type (2022-2028) 99
Figure 53. Global Paclitaxel Market Share Forecast by Type (2022-2028) 99
Figure 54. Global Paclitaxel Sales Forecast by Application (2022-2028) 100
Figure 55. Global Paclitaxel Market Share Forecast by Application (2022-2028) 101
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs